Covid-19 vaccination: Bharat
Biotech dispatches 1st batch of Covaxin, 20 million more doses ready
The first batch
of Covaxin has been sent to the Central Research Institute (CRI) in Kasauali
for further distribution, Bharat Biotech’s CMD Dr Krishna Ella said on Monday.
Covaxin
is a highly purified and inactivated vaccine, manufactured in a vero cell
manufacturing platform.
India is all set to begin the Covid-19 vaccination
drive in the next few days with two vaccines – Serum Institute of India’s
Covishield and Bharat Biotech’s Coavaxin. Also Read - COVID-19 Live Updates:
Cases in India surge to 10,340,469 while death toll reaches 1,49,649
Hyderabad-based Bharat Biotech has dispatched the
first batch of Covaxin for further distribution, said the company’s CMD Dr
Krishna Ella on Monday. Also Read - India approves Covishield
and Covaxin: Check the prices of the two Covid-19 vaccines
Addressing a press conference, Ella said that they
have already sent the batch to the Central Research Institute (CRI) in
Kasauali. CRI is the nodal agency to tests the drugs and facilitate in the roll
out to the northern part of the country. However, he did not disclose the quantity
of vials sent to the government. Also Read - Bharat Biotech claims its
Covid-19 vaccine generated excellent safety data, gets permission for sale
According to Ella, Bharat Biotech has 20 million doses
ready and will manufacture 80 million more by July. The company, which aims to
manufacture 700 million doses of Covaxin in future, is ramping up four new
facilities in south India – three in Hyderabad and one in Bangalore, he
revealed.
When asked about price of the vaccine, Ella only said
that it would be competitive with others. “Initially it may cost more but as
the production scales up, the price would come down with more competition in
the market,” he said.
Covid-19 Vaccine likely to reach Odisha by Jan 30
Source: https://www.thehealthsite.com/
No comments:
Post a Comment